Haemonetics Corporation Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt
Haemonetics Corporation (HAE) reported Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt of $28.33 million for the 12-month period ending 2024-03-30, per its 10-K filed 2025-05-21.
Financial Statements › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt · last filed 2025-05-21
- Haemonetics Corporation adjustments to additional paid in capital, equity component of convertible debt for fiscal 2024 was $28.33M.
- Haemonetics Corporation adjustments to additional paid in capital, equity component of convertible debt for fiscal 2021 was $61.16M.
| Period end | Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt 12 month |
|---|---|
| 2024-03-30 | $28.33M 10-K · filed 2025-05-21 |
| 2021-04-03 | $61.16M 10-K · filed 2023-05-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |